QRxPharma shares plummet 80%

Pharmaceutical group shares plunge after US FDA declines to approve its Moxduo product.

Shares in QRxPharma (QRX) have plummeted 80% in early trade after the Food and Drug Administration in the US failed to approve its pain drug, Moxduo.

At 11.20am (AEDT) QRxPharma shares were 79.29% lower at 14.5 cents, against a benchmark index lift of 0.67%. In earlier trade, QRxPharma shares hit as low as 10.5 cents.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles